We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMAO icon
5876
Farmers & Merchants Bancorp
FMAO
$481M
$146K ﹤0.01%
6,271
-8,975
-59% -$194K
MCRB icon
5877
Seres Therapeutics
MCRB
$48.4M
$145K ﹤0.01%
10,036
+4,738
+89% +$79K
ELDN icon
5878
Eledon Pharmaceuticals
ELDN
$285M
$145K ﹤0.01%
55,001
+54,997
+1,374,925% +$131K
SDPI
5879
DELISTED
Superior Drilling Products Inc.
SDPI
$145K ﹤0.01%
111,168
+98,753
+795% +$120K
CVE.WS
5880
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$144K ﹤0.01%
9,715
+7,962
+454% +$123K
SABA
5881
Saba Capital Income & Opportunities Fund II
SABA
$223M
$144K ﹤0.01%
18,493
-7,185
-28% -$54.9K
SERA icon
5882
Sera Prognostics
SERA
$81.1M
$144K ﹤0.01%
24,352
+3,695
+18% +$33K
ANVS icon
5883
CALL
Annovis Bio
ANVS
$80M
$144K ﹤0.01%
+25,000
New +$203K
GEF.B icon
5884
Greif Class B
GEF.B
$4.21B
$144K ﹤0.01%
2,300
-3,944
-63% -$255K
MLTX icon
5885
MoonLake Immunotherapeutics
MLTX
$1.55B
$144K ﹤0.01%
3,267
-11,485
-78% -$486K
LUNG icon
5886
Pulmonx
LUNG
$87.6M
$144K ﹤0.01%
22,635
-24,705
-52% -$190K
GNOV icon
5887
FT Vest US Equity Moderate Buffer ETF November
GNOV
$297M
$143K ﹤0.01%
4,245
-802
-16% -$26.6K
MYFW icon
5888
First Western Financial
MYFW
$306M
$143K ﹤0.01%
8,424
+449
+6% +$7.36K
EPM icon
5889
Evolution Petroleum
EPM
$131M
$143K ﹤0.01%
27,156
-22,978
-46% -$129K
VBFC
5890
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$143K ﹤0.01%
3,195
+426
+15% +$18.4K
NIU
5891
Niu Technologies
NIU
$193M
$143K ﹤0.01%
82,115
+75,275
+1,101% +$155K
NJAN icon
5892
Innovator Growth-100 Power Buffer ETF January
NJAN
$357M
$143K ﹤0.01%
+3,150
New +$138K
GRNT icon
5893
Granite Ridge Resources
GRNT
$644M
$143K ﹤0.01%
22,567
-66,588
-75% -$430K
DBAW icon
5894
Xtrackers MSCI All World ex US Hedged Equity ETF
DBAW
$293M
$143K ﹤0.01%
4,269
+2,337
+121% +$77.4K
DSGR icon
5895
Distribution Solutions Group
DSGR
$1.61B
$142K ﹤0.01%
4,744
-6,857
-59% -$228K
SAA icon
5896
ProShares Ulta SmallCap600
SAA
$30.5M
$142K ﹤0.01%
6,125
+5,857
+2,185% +$138K
DAC icon
5897
Danaos Corp
DAC
$2.56B
$142K ﹤0.01%
1,536
+1,151
+299% +$96K
HTB
5898
HomeTrust Bancshares
HTB
$848M
$142K ﹤0.01%
4,723
-10,108
-68% -$272K
EVMT icon
5899
Invesco Electric Vehicle Metals Commodity Strategy No K-1 ETF
EVMT
$7.14M
$142K ﹤0.01%
8,499
+7,987
+1,560% +$141K
EE icon
5900
Excelerate Energy
EE
$1.11B
$141K ﹤0.01%
7,664
-34,581
-82% -$594K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.